Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
PLoS One ; 8(4): e60933, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23613759

RESUMEN

Mycobacterium tuberculosis is a major human pathogen and the causative agent for the pulmonary disease, tuberculosis (TB). Current treatment programs to combat TB are under threat due to the emergence of multi-drug and extensively-drug resistant TB. As part of our efforts towards the discovery of new anti-tubercular leads, a number of potent tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide (THPP) and N-benzyl-6',7'-dihydrospiro[piperidine-4,4'-thieno[3,2-c]pyran] (Spiro) analogues were recently identified against Mycobacterium tuberculosis and Mycobacterium bovis BCG through a high-throughput whole-cell screening campaign. Herein, we describe the attractive in vitro and in vivo anti-tubercular profiles of both lead series. The generation of M. tuberculosis spontaneous mutants and subsequent whole genome sequencing of several resistant mutants identified single mutations in the essential mmpL3 gene. This 'genetic phenotype' was further confirmed by a 'chemical phenotype', whereby M. bovis BCG treated with both the THPP and Spiro series resulted in the accumulation of trehalose monomycolate. In vivo efficacy evaluation of two optimized THPP and Spiro leads showed how the compounds were able to reduce >2 logs bacterial cfu counts in the lungs of infected mice.


Asunto(s)
Antituberculosos/farmacología , Proteínas Bacterianas/antagonistas & inhibidores , Compuestos Bicíclicos Heterocíclicos con Puentes/farmacología , Mycobacterium tuberculosis/efectos de los fármacos , Pirazoles/farmacología , Compuestos de Espiro/farmacología , Animales , Antituberculosos/química , Antituberculosos/farmacocinética , Antituberculosos/uso terapéutico , Proteínas Bacterianas/metabolismo , Compuestos Bicíclicos Heterocíclicos con Puentes/química , Compuestos Bicíclicos Heterocíclicos con Puentes/farmacocinética , Compuestos Bicíclicos Heterocíclicos con Puentes/uso terapéutico , Cromatografía en Capa Delgada , Factores Cordón , Modelos Animales de Enfermedad , Perros , Farmacorresistencia Bacteriana , Genotipo , Células Hep G2 , Humanos , Cinética , Ratones , Pruebas de Sensibilidad Microbiana , Viabilidad Microbiana/efectos de los fármacos , Mutación/genética , Mycobacterium tuberculosis/genética , Mycobacterium tuberculosis/aislamiento & purificación , Pirazoles/química , Pirazoles/farmacocinética , Pirazoles/uso terapéutico , Ratas , Compuestos de Espiro/química , Compuestos de Espiro/farmacocinética , Compuestos de Espiro/uso terapéutico , Resultado del Tratamiento , Tuberculosis/tratamiento farmacológico , Tuberculosis/microbiología
2.
Bioorg Med Chem ; 18(5): 1822-33, 2010 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-20172734

RESUMEN

Finding small non-peptide molecules for G protein-coupled receptors (GPCR) whose endogenous ligands are peptides, is a very important task for medicinal chemists. Over the years, compounds mimicking peptide structures have been discovered, and scaffolds emulating peptide backbones have been designed. In our work on GPCR ligands, including cholecystokinin receptor-1 (CCKR-1) agonists, we have employed benzodiazepines as a core structure. Looking for ways to reduce molecular weight and possibly improve physical properties of GPCR ligands, we embarked on the search for molecules providing similar scaffolds to the benzodiazepine with lower molecular weight. One of our target core structures was 1,4-dihydro-[1,4]diazepine-5,7-dione. There was not, however, a known synthetic route to such molecules. Here we report the discovery of a simple and concise method for synthesis of 2-[6-(1H-indazol-3-ylmethyl)-5,7-dioxo-4-phenyl-4,5,6,7-tetrahydro-[1,4]diazepin-1-yl]-N-isopropyl-N-phenyl-acetamide as an example of a compound containing the tetrahydrodiazepine-5,7-dione core. Compounds from this series were tested in numerous GPCR assays and demonstrated activity at melanocortin 1 and 4 receptors (MC1R and MC4R). Selected compounds from this series were tested in vivo in Peptide YY (PYY)-induced food intake. Compounds dosed by intracerebroventricular and oral routes reduced PYY-induced food intake and this effect was reversed by the cyclic peptide MC4R antagonist SHU9119.


Asunto(s)
Azepinas/síntesis química , Ligandos , Hormonas Estimuladoras de los Melanocitos/síntesis química , Receptor de Melanocortina Tipo 1/agonistas , Receptor de Melanocortina Tipo 4/agonistas , Receptores Acoplados a Proteínas G/agonistas , Administración Oral , Animales , Azepinas/química , Azepinas/farmacocinética , Benzodiazepinas/química , Dicroismo Circular , Ingestión de Alimentos/efectos de los fármacos , Hormonas Estimuladoras de los Melanocitos/química , Hormonas Estimuladoras de los Melanocitos/farmacocinética , Péptidos/farmacología , Ratas , Ratas Sprague-Dawley , Receptor de Melanocortina Tipo 1/metabolismo , Receptor de Melanocortina Tipo 4/metabolismo , Receptores Acoplados a Proteínas G/metabolismo , Estereoisomerismo , Relación Estructura-Actividad
3.
Bioorg Med Chem Lett ; 19(10): 2637-41, 2009 May 15.
Artículo en Inglés | MEDLINE | ID: mdl-19376703

RESUMEN

Two classes of amino acid-derived heterocyclic progesterone receptor ligands were developed to address the metabolic issues posed by the dimethyl amide functionality of the lead compound (1). The tetrazole-derived ligands behaved as potent partial agonists, while the 1,2,4-triazole ligands behaved as potent full agonists.


Asunto(s)
Receptores de Progesterona/agonistas , Tetrazoles/síntesis química , Aminoácidos/química , Animales , Ratas , Receptores de Progesterona/metabolismo , Relación Estructura-Actividad , Tetrazoles/química , Tetrazoles/farmacocinética
4.
Chirality ; 19(9): 731-40, 2007 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-17575572

RESUMEN

GT-2331 [(+)-1] is one of the most potent members of a class of chiral drug substances used to regulate the synthesis and release of histamine by the histamine H3 receptor, and as such, is an important biomarker for pharmaceutical companies conducting research in this field. In addition to overall structural features, the bioactivity of this molecule has also been found to be highly dependent on absolute stereochemistry, making the reliable assignment of this property a necessity. X-ray diffraction studies have provided conflicting data, leaving its three-dimensional structure uncertain. In view of this, its absolute configuration was investigated by vibrational circular dichroism. Results from this study provided independent assignment of this important molecule as the (1S,2S)-enantiomer.


Asunto(s)
Química Farmacéutica/métodos , Dicroismo Circular/métodos , Antagonistas de los Receptores Histamínicos/química , Imidazoles/farmacología , Receptores Histamínicos H3/química , Dimerización , Diseño de Fármacos , Humanos , Enlace de Hidrógeno , Modelos Químicos , Conformación Molecular , Espectrofotometría Infrarroja/métodos , Estereoisomerismo , Termodinámica , Difracción de Rayos X
5.
Org Lett ; 4(3): 323-6, 2002 Feb 07.
Artículo en Inglés | MEDLINE | ID: mdl-11820870

RESUMEN

A solid-phase synthesis of substituted benzopyranoisoxazoles is described. The six-step synthesis features a novel method of generating nitrile oxides on a polymer support followed by an intramolecular 1,3-dipolar cycloaddition with a tethered alkyne for assembly of the benzopyranoisoxazole scaffold. Furthermore, the utilization of single-bead attenuated total reflectance Fourier transform infrared (ATR-IR) microspectroscopy as an essential analytical tool for reaction optimization is highlighted.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA